M. Pfau

发表

Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia

C. Eckert, G. Henze, K. Seeger, 2010, Journal of Molecular Medicine.

The Thalidomide Analogue, CC-4047, Induces Apoptosis Signaling and Growth Arrest in Childhood Acute Lymphoblastic Leukemia Cells In vitro and In vivo

I. Fichtner, G. Henze, K. Seeger, 2006, Clinical Cancer Research.

CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment

C. Eckert, S. Izraeli, U. Höpken, 2022, The Journal of pathology.

Antiproliferative Properties of the Serotonin Receptor Antagonist Ondansetron Correlate with Increased Nitric Oxides Release and Inducible Nitric Oxide Synthase Activity in the Acute Lymphoblastic Leukemia Cell Line REH

K. Seeger, G. Henze, J. Prada, 2012 .

Antiproliferative effect of the serotonin receptor antagonist ondansetron in the acute lymphoblastic leukemia cell line REH

K. Seeger, G. Henze, J. Prada, 2011, Acta oncologica.

The Serotonin Receptor‐Antagonist Ondansetron Induces Significant Increases in the Expression of Interferon‐Gamma Which Correlate with Antiproliferative Properties in the Acute Lymphoblastic Leukaemia Cell Line REH

G. Henze, K. Seeger, J. Prada, 2012, Scandinavian journal of immunology.

Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB

C. Eckert, I. Fichtner, G. Henze, 2013, Clinical Cancer Research.

of p 53 , PI 3 K / AKT , and NF-of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation Synergistic Activity of Bortezomib and HDACi in Preclinical Models

C. Eckert, I. Fichtner, K. Seeger, 2013 .

Cancer Therapy : Preclinical Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p 53 , PI 3 K / AKT , and NFk B

C. Eckert, I. Fichtner, K. Seeger, 2013 .

Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB

C. Eckert, I. Fichtner, G. Henze, 2013, Clinical Cancer Research.